Radiation Oncology

Basic and clinical research to improve quality and efficacy of intensity modulated radiation therapy (IMRT) by achieving highly-optimized dose distributions and to promote its application to a wide range of cancers, including head and neck cancers, malignant glioma, prostate cancers, and uterine cervical cancers.
Studies on quality assurance of verification and high precision radiation delivery by image-guided radiotherapy (IGRT) using real-time imaging technology.
Studies on contouring targets and risk organs by automatic and deformable image registration technology as well as image fusion technology using CT, MRI, and various molecular images.
Studies on mechanism of treatment-related toxicity of normal tissues (i.e., radiation pneumonitis) and on its reduction via eliminating unnecessary dose by IMRT, IGRT, and respiratory gating technology.
Participation and co-operation in nationwide clinical research trialists group as follows:JCOG (Japan Clinical Oncology Group), WJOG (West Japan Oncology Group), JROSG (Japanese Radiation Oncology Study Group)

Dosimetric comparison of nodal clinical target volume for locally advanced non‑small cell lung cancer: Options for geometric expansion vs. lymph node stations. Takahashi S, Anada M, Kinoshita T, et al. Mol Clin Oncol. 2024;21(2):57. PMID: 39006473
Radiotherapy for cytokeratin-positive interstitial reticulum cell (CIRC) tumor on epicardium: a case report. Anada M, Fujita H, Ishikawa R, Takahashi S, et al. Int Cancer Conf J. 2024;14(1):27-34. PMID: 39758794
A retrospective study of locally advanced cervical cancer cases treated with CT-based 3D-IGBT compared with 2D-IGBT. Kinoshita T, Takahashi S, Anada M, et al. Jpn J Radiol. 2023 Oct;41(10):1164-1172. PMID: 37140821

E-mail: